Suzhou Institute of Systems Medicine
- World rank, 2022–2025
- #6,465 of 28,054 · #10,406 all time
- Rank in China
- #1,349 of 3,058
- Research works
- 188 ▲ 365% vs 2013–17
- Citations
- 7k 37.3 per fractional work
- Top-10% rate
- 28.2% record average 16.5%
- Open access
- 63% world 28%
What does Suzhou Institute of Systems Medicine specialise in?
Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 6.4× the share of its output that it takes of world research.
- Biochemistry, Genetics and Molecular BiologyField · 25.6 works6.4×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 16.8×. Every wedge is a field page.
- Immunology and Microbiology 16.8×
- Biochemistry, Genetics and Molecular Biology 6.4×
- Medicine 1.9×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Neuroscience 0.8×
- Agricultural and Biological Sciences 0.5×
- Chemistry 0.4×
- Mathematics 0.4×
- Nursing 0.4×
- Dentistry 0.3×
- Computer Science 0.3×
- Environmental Science 0.1×
- Engineering 0.1×
- Materials Science 0.1×
- Health Professions 0.1×
- Economics, Econometrics and Finance 0.1×
- Earth and Planetary Sciences 0.1×
- Physics and Astronomy 0.1×
- Psychology 0.1×
Which keywords describe research at Suzhou Institute of Systems Medicine?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Epidemiology, Immunity, Vaccine, Inflammation, Pathogenesis, Innate Immunity and Immune Response.
- Autoimmunity
- Genomics
- Vaccine Development
- Gene Therapy
- Activation
- Single-Cell
- antibody
- NK Cell Recognition
- Mutation
- RNA-Seq
- Data Integration
- ACE2 Receptor
- Viral Infection
- SARS-CoV-2
- Tumor Microenvironment
- Pandemic
- Gene Expression
- Pathogenesis
- Immunity
- Cancer
- Epidemiology
- Inflammation
- Vaccine
- Innate Immunity
- Immune Response
- Pattern Recognition Receptors
- Coronavirus
- Cancer Immunotherapy
- Immunotherapy
- Metabolism
- Interferon Signaling
- cGAS-STING Pathway
- Viral Transmission
- Natural Killer Cells
- spike protein
- Transcriptomics
- Epigenetic Regulation
- Macrophage
- Antigen Presentation
- Cancer Progression
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology10▲ 3.4×34 topics
- Cancer8▲ 7.7×28 topics
- Inflammation7▲ 4.5×39 topics
- Immunity6▲ 21×7 topics
- Vaccine6▲ 20×9 topics
- Pathogenesis5▲ 14×11 topics
- Innate Immunity4▲ 18×6 topics
- Gene Expression4▲ 9.3×10 topics
- Immune Response4▲ 10.0×15 topics
- Pandemic4▲ 4.8×4 topics
- Pattern Recognition Receptors4▲ 37×2 topics
- Tumor Microenvironment4▲ 10×8 topics
- Coronavirus3▲ 21×2 topics
- SARS-CoV-23▲ 14×4 topics
- Cancer Immunotherapy3▲ 25×3 topics
- Viral Infection3▲ 57×2 topics
- Immunotherapy3▲ 5.3×12 topics
- ACE2 Receptor3▲ 14×2 topics
- Metabolism3▲ 6.9×11 topics
- Data Integration2▲ 20×2 topics
- Interferon Signaling2▲ 89×1 topic
- RNA-Seq2▲ 29×2 topics
- cGAS-STING Pathway2▲ 89×1 topic
- Mutation2▲ 16×2 topics
- Viral Transmission2▲ 21×2 topics
- NK Cell Recognition2▲ 44×1 topic
- Natural Killer Cells2▲ 44×1 topic
- antibody2▲ 27×1 topic
- spike protein2▲ 27×1 topic
- Single-Cell2▲ 59×1 topic
- Transcriptomics2▲ 59×1 topic
- Activation2▲ 41×1 topic
- Epigenetic Regulation2▲ 12×3 topics
- Gene Therapy2▲ 13×4 topics
- Macrophage2▲ 34×1 topic
- Vaccine Development2▲ 10×5 topics
- Antigen Presentation2▲ 27×2 topics
- Genomics2▲ 7.9×4 topics
- Cancer Progression2▲ 12×4 topics
- Autoimmunity2▲ 15×4 topics
Which research topics does Suzhou Institute of Systems Medicine publish most on?
By volume in 2022–2025: interferon and immune responses, SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction and Single-cell and spatial transcriptomics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 interferon and immune responses Immunology 2 works
- 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
- 3 Immune Cell Function and Interaction Immunology 2 works
- 4 Single-cell and spatial transcriptomics Molecular Biology 2 works
- 5 Immune cells in cancer Immunology 2 works
- 6 RNA Research and Splicing Molecular Biology 1 works
- 7 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 8 RNA modifications and cancer Molecular Biology 1 works
- 9 CAR-T cell therapy research Oncology 1 works
- 10 RNA and protein synthesis mechanisms Molecular Biology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Suzhou Institute of Systems Medicine's research output changed?
Output in 2018–2022 was 365% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Suzhou
- Soochow University
- Suzhou University of Science and Technology
- Xi’an Jiaotong-Liverpool University
- First Affiliated Hospital of Soochow University
- Suzhou Research Institute
- Second Affiliated Hospital of Soochow University
- Suzhou Institute of Nano-tech and Nano-bionics
- Suzhou Vocational University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.